Inventor · disambiguated record
James N. Leonard
Also filed as: LEONARD JAMES · LEONARD JAMES N
37 granted patents·11 pending applications·160 citations·filing 1995–2024
97Inventor score
Top patents by PatentIndex Score
48 records- 0197US11767354B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Sep 26, 2023·3 cites·23 claims
- 0296US10428134B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Oct 1, 2019·7 cites·21 claims
- 0395US11591379B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Feb 28, 2023·3 cites·20 claims
- 0495US7108991B2Human orphan G protein-coupled receptorsARENA PHARM INC·Filed 2003·Granted Sep 19, 2006·38 cites·11 claims
- 0594US10968265B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Apr 6, 2021·4 cites·24 claims
- 0694US10787495B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Sep 29, 2020·3 cites·20 claims
- 0794US10640544B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted May 5, 2020·4 cites·28 claims
- 0893US11401315B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Aug 2, 2022·2 cites·24 claims
- 0993US10858413B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Dec 8, 2020·3 cites·17 claims
- 1092US2025026803A1Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 1187US7803753B2Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 levelARENA PHARM INC·Filed 2006·Granted Sep 28, 2010·6 cites·11 claims
- 1286US2023365644A1Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide y receptorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 1385US8198232B2Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 levelCHU ZHI-LIANG·Filed 2009·Granted Jun 12, 2012·5 cites·66 claims
- 1483US8354241B2Methods for identifying a GLP-1 secretagogueARENA PHARM INC·Filed 2006·Granted Jan 15, 2013·5 cites·30 claims
- 1583US7833730B2Methods of using GPR119 to identify compounds useful for increasing bone mass in an individualARENA PHARM INC·Filed 2007·Granted Nov 16, 2010·4 cites·69 claims
- 1682US7816364B2GRP119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating theretoARENA PHARM INC·Filed 2007·Granted Oct 19, 2010·4 cites·171 claims
- 1781US8030270B2Methods for identifying GLP-1 secretagoguesARENA PHARM INC·Filed 2009·Granted Oct 4, 2011·2 cites·9 claims
- 1881US8022034B2Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 levelARENA PHARM INC·Filed 2009·Granted Sep 20, 2011·2 cites·34 claims
- 1981US8003597B2Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 levelARENA PHARM INC·Filed 2009·Granted Aug 23, 2011·2 cites·30 claims
- 2080US8101626B2GPR119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating theretoCHU ZHI-LIANG·Filed 2010·Granted Jan 24, 2012·4 cites·38 claims
- 2180US7803754B2Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 levelARENA PHARM INC·Filed 2006·Granted Sep 28, 2010·2 cites·24 claims
- 2279US8580526B2Methods of using GPR119 receptor to identify compounds which stimulate glucose-dependent insulinotropic peptide secretionCHU ZHI-LIANG·Filed 2011·Granted Nov 12, 2013·3 cites·33 claims
- 2379US7838254B2Methods of using GPR119 to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYYARENA PHARM INC·Filed 2009·Granted Nov 23, 2010·2 cites·27 claims
- 2478US12134636B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Nov 5, 2024·0 cites·35 claims
- 2578US8486646B2Methods of using a G protein-coupled receptor to identify peptide YY (PYY) secretagoguesCHU ZHI-LIANG·Filed 2010·Granted Jul 16, 2013·3 cites·166 claims
- 2677US8026212B2Methods of preparing pharmaceutical compositions comprising GPR119 agonists having the effect of glucose-dependent insulinotropic peptide secretatgoguesARENA PHARM INC·Filed 2010·Granted Sep 27, 2011·2 cites·26 claims
- 2777US8026074B2Methods of using GPR119 to identify compounds useful for increasing bone mass in an individualARENA PHARM INC·Filed 2010·Granted Sep 27, 2011·2 cites·17 claims
- 2877US8017574B2Methods of preparing pharmaceutical compositions comprising GPR119 agonists having the effect of glucose-dependent insulinotropic peptide secretagoguesARENA PHARM INC·Filed 2010·Granted Sep 13, 2011·2 cites·36 claims
- 2975US7119190B2Endogenous and non-endogenous versions of human G protein-coupled receptorsARENA PHARM INC·Filed 2002·Granted Oct 10, 2006·9 cites·8 claims
- 3071US9182414B2Methods for identifying a GLP-1 secretagogueARENA PHARM INC·Filed 2012·Granted Nov 10, 2015·1 cites·52 claims
- 3167US2010137293A1Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 levelARENA PHARM INC·Filed 2009·Application pending·0 cites
- 3263US7816492B2Human G protein-coupled receptorsARENA PHARM INC·Filed 2006·Granted Oct 19, 2010·0 cites·55 claims
- 3363US2005004178A1Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disordersARENA PHARM INC·Filed 2004·Application pending·0 cites
- 3462US5741673ANucleic acid encoding a novel homeobox factor which stimulates insulin expression in pancreatic islet cellsRES DEV FOUNDATION·Filed 1996·Granted Apr 21, 1998·23 cites·9 claims
- 3561US8097452B2Human orphan G protein-coupled receptorsCHEN RUOPING·Filed 2002·Granted Jan 17, 2012·0 cites·3 claims
- 3661US2007079392A1Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disordersARENA PHARM INC·Filed 2006·Application pending·0 cites
- 3759US8883714B2Pharmaceutical compositions comprising GPR119 agonists which act as peptide YY (PYY) secretagoguesARENA PHARM INC·Filed 2013·Granted Nov 11, 2014·0 cites·11 claims
- 3859US8039219B2Method of using GPR35 to identify metabolic-stabilizing compoundsARENA PHARM INC·Filed 2006·Granted Oct 18, 2011·0 cites·4 claims
- 3959US2006154866A1Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 levelCHU ZHI-LIANG·Filed 2006·Application pending·0 cites
- 4053US2011177612A1Human G Protein-Coupled Receptors and Modulators Thereof for the Treatment of Metabolic-Related DisordersUNETT DAVID J·Filed 2010·Application pending·0 cites
- 4152US7829298B2Human G protein-coupled receptors for metabolic-related disordersARENA PHARM INC·Filed 2004·Granted Nov 9, 2010·0 cites·18 claims
- 4249USRE42190EMethod of identifying a compound for inhibiting or stimulating human G protein-coupled receptorsARENA PHARM INC·Filed 2007·Granted Mar 1, 2011·0 cites·32 claims
- 4346US2011319451A15-Ht6 Receptor and Modulators Thereof for the Treatment of Insulin-Related DisordersLEONARD JAMES N·Filed 2009·Application pending·0 cites
- 4443US5955579AIslet-specific homeoprotein and transcriptional regulator of insulin gene expression, HOXB13STRANG CANCER PREVENTION CENTE·Filed 1995·Granted Sep 21, 1999·10 cites·10 claims
- 4541US2006240523A1Endogenous and non-endogenous versions of human G protein-coupled receptorsARENA PHARM INC·Filed 2006·Application pending·0 cites
- 4640US2012208843A1Method of Using GPR35 to Identify Metabolic-Stabilizing CompoundsLEONARD JAMES N·Filed 2011·Application pending·0 cites
- 4736US9017949B2Method of screening for compounds useful in the treatment of insulin resistance, impaired glucose tolerance or diabetesLEONARD JAMES N·Filed 2005·Granted Apr 28, 2015·0 cites·4 claims
- 4836US2008312277A1Gpr41 and Modulators Thereof for the Treatment of Insulin-Related DisordersLEONARD JAMES N·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James N. Leonard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →